Secondary Logo

Institutional members access full text with Ovid®

CD8+ T cells

mechanistic target of rapamycin and eukaryotic initiation factor 2 in elite HIV-1 control

Nyanhete, Tinashea,d; Tomaras, Georgia D.a,b,c,d

doi: 10.1097/QAD.0000000000002008
Editorial Comments

aDepartment of Immunology

bDepartment of Surgery

cDepartment of Molecular Genetics and Microbiology

dDuke Human Vaccine Institute, Durham, North Carolina, USA.

Correspondence to Georgia D. Tomaras, PhD, Departments of Surgery, Immunology, Molecular Genetics and Microbiology, and the Duke Human Vaccine Institute, Durham, NC 27710, USA. Tel: +1 919 681 5598; e-mail:

Received 15 June, 2018

Accepted 13 August, 2018

Copyright © 2018 Wolters Kluwer Health, Inc.